FDA Adverse Event Malfunction Summary report: N

COULTER® ACT¿ 5DIFF CAP PIERCE (CP)

MDR report key: 2250556 · Received September 16, 2011

Report

Report Number
1061932-2011-01474
Event Type
Malfunction
Date Received
September 16, 2011
Date of Event
August 16, 2011
Report Date
August 16, 2011
Manufacturer
BECKMAN COULTER INC.
Product Code
GKZ
PMA / PMN Number
K042173
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SERVICE WAS DISPATCHED TO THE SITE ON (B)(4) 2011 FOR THIS EVENT. THE FIELD SERVICE ENGINEER (FSE) FOUND THAT THE REAGENT SYRINGE BLOCK HAD A CRACK AT THE HEMOGLOBIN LYSE SYRINGE. THE FSE REPLACED THE LEAKING REAGENT SYRINGE. THE INSTRUMENT WAS RETURNED INTO SERVICE AFTER COMPLETION OF VERIFIED REPAIRS. THE ROOT CAUSE FOR THIS EVENT IS ATTRIBUTED TO A CRACKED HGB LYSE SYRINGE

Description of Event or Problem · 1

THE CUSTOMER INDICATED THAT THEY OBSERVED A HEMOGLOBIN (HGB) LYSE LEAK UNDERNEATH THE COULTER ACT 5DIFF CAP PIERCE (CP) INSTRUMENT. THE HEALTHCARE WORKERS INTERFACING WITH THE MACHINE WERE WEARING PERSONAL PROTECTIVE EQUIPMENT, WHICH INCLUDED LABORATORY COATS AND GLOVES, AT THE TIME OF OCCURRENCE THERE WAS NO BIOHAZARDOUS EXPOSURE TO HEALTHCARE WORKER UNCOVERED WOUNDS OR MUCOUS MEMBRANES AND NO INJURIES WERE REPORTED. NO PERSONNEL SOUGHT ANY MEDICAL ATTENTION IN ASSOCIATION WITH THIS EVENT. BECKMAN COULTER INC. PERSONNEL REVIEWED CUSTOMER PATIENT DATA AND FOUND THAT NO PATIENT RESULTS WERE AFFECTED BY THE LEAK. THE LEAK WAS FOUND BEFORE THE START UP OF THE DAY AND THE CUSTOMER DID NOT RUN SAMPLES AFTER THE LEAK WAS FOUND. NO DEATH, INJURY OR MODIFICATION TO PATIENT TREATMENT WAS ASSOCIATED WITH THIS EVENT. THERE WAS AN EXPOSURE PLAN IN PLACE AT THE FACILITY AND A MATERIAL SAFETY DATA SHEET WAS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COULTER® ACT¿ 5DIFF CAP PIERCE (CP) COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1